What is Polyrizon Ltd. Ordinary Shares?
, a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 26.84M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.